TreeWAS – Variant ID: rs67947502

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.057	0.943
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.055	0.945
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.055	0.945
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.051	0.949
T43.2 Other and unspecified antidepressants	0.050	0.950
T43.0 Tricyclic and tetracyclic antidepressants	0.049	0.951
Chapter VII Diseases of the eye and adnexa	0.048	0.952
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.048	0.952
T51 Toxic effect of alcohol	0.048	0.952
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.047	0.953
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.046	0.954
Chapter I Certain infectious and parasitic diseases	0.045	0.955
# Top node	0.045	0.955
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.045	0.955
S20-S29 Injuries to the thorax	0.045	0.955
H53-H54 Visual disturbances and blindness	0.044	0.956
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.044	0.956
S70-S79 Injuries to the hip and thigh	0.044	0.956
S00-S09 Injuries to the head	0.044	0.956
T43.5 Other and unspecified antipsychotics and neuroleptics	0.044	0.956
T51.0 Ethanol	0.043	0.957
M50-M54 Other dorsopathies	0.043	0.957
S40-S49 Injuries to the shoulder and upper arm	0.043	0.957
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.043	0.957
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.042	0.957
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.042	0.958
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.042	0.958
M70-M79 Other soft tissue disorders	0.042	0.958
A00-A09 Intestinal infectious diseases	0.042	0.958
H55-H59 Other disorders of eye and adnexa	0.042	0.958
T51.9 Alcohol, unspecified	0.042	0.958
T40.2 Other opioids	0.042	0.958
A30-A49 Other bacterial diseases	0.042	0.958
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.041	0.959
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.041	0.959
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.041	0.959
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.041	0.959
T46 Poisoning by agents primarily affecting the cardiovascular system	0.041	0.959
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.041	0.959
T41 Poisoning by anaesthetics and therapeutic gases	0.041	0.959
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.041	0.959
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.041	0.959
T36 Poisoning by systemic antibiotics	0.041	0.959
T15-T19 Effects of foreign body entering through natural orifice	0.041	0.959
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.041	0.959
M54 Dorsalgia	0.041	0.959
H40-H42 Glaucoma	0.041	0.959
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.040	0.959
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.040	0.960
T43.9 Psychotropic drug, unspecified	0.040	0.960
T43.8 Other psychotropic drugs, not elsewhere classified	0.040	0.960
T43.6 Psychostimulants with abuse potential	0.040	0.960
T43.4 Butyrophenone and thioxanthene neuroleptics	0.040	0.960
T43.3 Phenothiazine antipsychotics and neuroleptics	0.040	0.960
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.040	0.960
S09 Other and unspecified injuries of head	0.040	0.960
H53 Visual disturbances	0.040	0.960
T33-T35 Frostbite	0.040	0.960
T26-T28 Burns and corrosions confined to eye and internal organs	0.040	0.960
T20-T25 Burns and corrosions of external body surface, specified by site	0.040	0.960
T00-T07 Injuries involving multiple body regions	0.040	0.960
S10-S19 Injuries to the neck	0.040	0.960
T66-T78 Other and unspecified effects of external causes	0.039	0.961
S90-S99 Injuries to the ankle and foot	0.039	0.961
S50-S59 Injuries to the elbow and forearm	0.039	0.961
Chapter XX External causes of morbidity and mortality	0.039	0.961
A41 Other septicaemia	0.039	0.961
Chapter VI Diseases of the nervous system	0.039	0.961
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.038	0.962
T79-T79 Certain early complications of trauma	0.038	0.962
M05-M14 Inflammatory polyarthropathies	0.038	0.962
T42.4 Benzodiazepines	0.038	0.962
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.038	0.962
Chapter XXII Codes for special purposes	0.037	0.962
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.037	0.963
H54 Blindness and low vision	0.037	0.963
M77 Other enthesopathies	0.037	0.963
S09.9 Unspecified injury of head	0.037	0.963
H43-H45 Disorders of vitreous body and globe	0.037	0.963
T65 Toxic effect of other and unspecified substances	0.036	0.963
T63 Toxic effect of contact with venomous animals	0.036	0.963
T62 Toxic effect of other noxious substances eaten as food	0.036	0.963
T61 Toxic effect of noxious substances eaten as seafood	0.036	0.963
T60 Toxic effect of pesticides	0.036	0.963
T59 Toxic effect of other gases, fumes and vapours	0.036	0.963
T57 Toxic effect of other inorganic substances	0.036	0.963
T56 Toxic effect of metals	0.036	0.963
T54 Toxic effect of corrosive substances	0.036	0.963
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.036	0.963
T52 Toxic effect of organic solvents	0.036	0.963
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.036	0.963
T58 Toxic effect of carbon monoxide	0.036	0.963
T55 Toxic effect of soaps and detergents	0.036	0.963
M80-M85 Disorders of bone density and structure	0.036	0.964
M40-M43 Deforming dorsopathies	0.036	0.964
M54.5 Low back pain	0.036	0.964
N40-N51 Diseases of male genital organs	0.036	0.964
H10-H13 Disorders of conjunctiva	0.036	0.964
S40 Superficial injury of shoulder and upper arm	0.036	0.964
B35-B49 Mycoses	0.035	0.965
G90-G99 Other disorders of the nervous system	0.035	0.965
W00-W19 Falls	0.035	0.965
H40 Glaucoma	0.035	0.965
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.035	0.965
Chapter V Mental and behavioural disorders	0.035	0.965
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.035	0.965
A41.1 Septicaemia due to other specified staphylococcus	0.035	0.965
M91-M94 Chondropathies	0.035	0.965
M45-M49 Spondylopathies	0.035	0.965
B15-B19 Viral hepatitis	0.035	0.965
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.035	0.965
S79 Other and unspecified injuries of hip and thigh	0.035	0.965
S27 Injury of other and unspecified intrathoracic organs	0.035	0.965
H50 Other strabismus	0.035	0.965
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.035	0.965
H46-H48 Disorders of optic nerve and visual pathways	0.035	0.965
S30 Superficial injury of abdomen, lower back and pelvis	0.035	0.965
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.034	0.965
T40.8 Lysergide [LSD]	0.034	0.965
T40.7 Cannabis (derivatives)	0.034	0.965
T40.6 Other and unspecified narcotics	0.034	0.965
T40.5 Cocaine	0.034	0.965
T40.4 Other synthetic narcotics	0.034	0.965
T40.3 Methadone	0.034	0.965
T40.1 Heroin	0.034	0.965
T40.0 Opium	0.034	0.965
H21 Other disorders of iris and ciliary body	0.035	0.965
T51.8 Other alcohols	0.034	0.965
T51.3 Fusel oil	0.034	0.965
T51.2 2-Propanol	0.034	0.965
T51.1 Methanol	0.034	0.965
N40 Hyperplasia of prostate	0.034	0.966
A09.9 Gastroenteritis and colitis of unspecified origin	0.034	0.966
H53.1 Subjective visual disturbances	0.034	0.966
S22 Fracture of rib(s), sternum and thoracic spine	0.034	0.966
A04 Other bacterial intestinal infections	0.034	0.966
H20 Iridocyclitis	0.034	0.966
Chapter XIV Diseases of the genitourinary system	0.034	0.966
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.034	0.966
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.034	0.966
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.034	0.966
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.034	0.966
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.034	0.966
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.034	0.966
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.034	0.966
T44.1 Other parasympathomimetics [cholinergics]	0.034	0.966
T44.0 Anticholinesterase agents	0.034	0.966
S29 Other and unspecified injuries of thorax	0.034	0.966
M54.4 Lumbago with sciatica	0.034	0.966
H57 Other disorders of eye and adnexa	0.034	0.966
A02 Other Salmonella infections	0.034	0.966
A50-A64 Infections with a predominantly sexual mode of transmission	0.034	0.966
T31 Burns classified according to extent of body surface involved	0.034	0.966
S32 Fracture of lumbar spine and pelvis	0.034	0.966
H53.0 Amblyopia ex anopsia	0.034	0.966
T14 Injury of unspecified body region	0.033	0.966
M72 Fibroblastic disorders	0.034	0.966
S72 Fracture of femur	0.033	0.966
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.033	0.967
H55 Nystagmus and other irregular eye movements	0.033	0.967
T90 Sequelae of injuries of head	0.033	0.967
M60-M63 Disorders of muscles	0.033	0.967
M00-M03 Infectious arthropathies	0.033	0.967
S00 Superficial injury of head	0.033	0.967
S70 Superficial injury of hip and thigh	0.033	0.967
H53.8 Other visual disturbances	0.033	0.967
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.033	0.967
D50-D53 Nutritional anaemias	0.033	0.967
B99-B99 Other infectious diseases	0.033	0.967
B90-B94 Sequelae of infectious and parasitic diseases	0.033	0.967
B85-B89 Pediculosis, acariasis and other infestations	0.033	0.967
B65-B83 Helminthiases	0.033	0.967
B50-B64 Protozoal diseases	0.033	0.967
B20-B24 Human immunodeficiency virus [HIV] disease	0.033	0.967
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.033	0.967
A80-A89 Viral infections of the central nervous system	0.033	0.967
A75-A79 Rickettsioses	0.033	0.967
A70-A74 Other diseases caused by chlamydiae	0.033	0.967
A65-A69 Other spirochaetal diseases	0.033	0.967
A20-A28 Certain zoonotic bacterial diseases	0.033	0.967
A15-A19 Tuberculosis	0.033	0.967
H18 Other disorders of cornea	0.033	0.967
M50 Cervical disk disorders	0.033	0.967
Chapter XVI Certain conditions originating in the perinatal period	0.033	0.967
G93 Other disorders of brain	0.033	0.967
M06 Other rheumatoid arthritis	0.033	0.967
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.033	0.967
S20 Superficial injury of thorax	0.032	0.967
M86-M90 Other osteopathies	0.032	0.968
M79 Other soft tissue disorders, not elsewhere classified	0.032	0.968
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.032	0.968
S37 Injury of urinary and pelvic organs	0.032	0.968
S36 Injury of intra-abdominal organs	0.032	0.968
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.032	0.968
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.032	0.968
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.032	0.968
S31 Open wound of abdomen, lower back and pelvis	0.032	0.968
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.032	0.968
S26 Injury of heart	0.032	0.968
S25 Injury of blood vessels of thorax	0.032	0.968
S24 Injury of nerves and spinal cord at thorax level	0.032	0.968
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.032	0.968
S21 Open wound of thorax	0.032	0.968
M70 Soft tissue disorders related to use, overuse and pressure	0.032	0.968
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.032	0.968
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.032	0.968
T42.5 Mixed antiepileptics, not elsewhere classified	0.032	0.968
T42.3 Barbiturates	0.032	0.968
T42.2 Succinimides and oxazolidinediones	0.032	0.968
T42.1 Iminostilbenes	0.032	0.968
T42.0 Hydantoin derivatives	0.032	0.968
N43 Hydrocele and spermatocele	0.032	0.968
S78 Traumatic amputation of hip and thigh	0.032	0.968
S77 Crushing injury of hip and thigh	0.032	0.968
S76 Injury of muscle and tendon at hip and thigh level	0.032	0.968
S75 Injury of blood vessels at hip and thigh level	0.032	0.968
S74 Injury of nerves at hip and thigh level	0.032	0.968
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.032	0.968
S71 Open wound of hip and thigh	0.032	0.968
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.032	0.968
H25-H28 Disorders of lens	0.032	0.968
S08 Traumatic amputation of part of head	0.032	0.968
S07 Crushing injury of head	0.032	0.968
S05 Injury of eye and orbit	0.032	0.968
S04 Injury of cranial nerves	0.032	0.968
S03 Dislocation, sprain and strain of joints and ligaments of head	0.032	0.968
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.032	0.968
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.032	0.968
N45 Orchitis and epididymitis	0.032	0.968
S80-S89 Injuries to the knee and lower leg	0.031	0.968
S06 Intracranial injury	0.031	0.969
A41.5 Septicaemia due to other Gram-negative organisms	0.031	0.969
M54.9 Dorsalgia, unspecified	0.031	0.969
H40.0 Glaucoma suspect	0.031	0.969
G80-G83 Cerebral palsy and other paralytic syndromes	0.031	0.969
A41.8 Other specified septicaemia	0.031	0.969
M53 Other dorsopathies, not elsewhere classified	0.031	0.969
A49 Bacterial infection of unspecified site	0.031	0.969
S49 Other and unspecified injuries of shoulder and upper arm	0.031	0.969
S48 Traumatic amputation of shoulder and upper arm	0.031	0.969
S46 Injury of muscle and tendon at shoulder and upper arm level	0.031	0.969
S45 Injury of blood vessels at shoulder and upper arm level	0.031	0.969
S44 Injury of nerves at shoulder and upper arm level	0.031	0.969
S41 Open wound of shoulder and upper arm	0.031	0.969
S47 Crushing injury of shoulder and upper arm	0.031	0.969
T32 Corrosions classified according to extent of body surface involved	0.031	0.969
T30 Burn and corrosion, body region unspecified	0.031	0.969
T29 Burns and corrosions of multiple body regions	0.031	0.969
S90 Superficial injury of ankle and foot	0.031	0.969
T13 Other injuries of lower limb, level unspecified	0.031	0.969
T11 Other injuries of upper limb, level unspecified	0.031	0.969
T09 Other injuries of spine and trunk, level unspecified	0.031	0.969
T12.X1 Fracture of lower limb, level unspecified (open)	0.031	0.969
T12.X0 Fracture of lower limb, level unspecified (closed)	0.031	0.969
T12 Fracture of lower limb, level unspecified	0.031	0.969
T10.X1 Fracture of upper limb, level unspecified (open)	0.031	0.969
T10.X0 Fracture of upper limb, level unspecified (closed)	0.031	0.969
T10 Fracture of upper limb, level unspecified	0.031	0.969
T08.X1 Fracture of spine, level unspecified (open)	0.031	0.969
T08.X0 Fracture of spine, level unspecified (closed)	0.031	0.969
T08 Fracture of spine, level unspecified	0.031	0.969
H52 Disorders of refraction and accommodation	0.031	0.969
M54.3 Sciatica	0.031	0.969
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.030	0.969
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.030	0.969
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.030	0.969
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.030	0.969
H17 Corneal scars and opacities	0.030	0.969
H16 Keratitis	0.030	0.969
H15 Disorders of sclera	0.030	0.969
T18 Foreign body in alimentary tract	0.030	0.969
T98 Sequelae of other and unspecified effects of external causes	0.030	0.969
T95 Sequelae of burns, corrosions and frostbite	0.030	0.969
T94 Sequelae of injuries involving multiple and unspecified body regions	0.030	0.969
T93 Sequelae of injuries of lower limb	0.030	0.969
T92 Sequelae of injuries of upper limb	0.030	0.969
T91 Sequelae of injuries of neck and trunk	0.030	0.969
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.030	0.969
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.030	0.969
M76 Enthesopathies of lower limb, excluding foot	0.030	0.970
M73 Soft tissue disorders in diseases classified elsewhere	0.030	0.970
M71 Other bursopathies	0.030	0.970
M77.9 Enthesopathy, unspecified	0.030	0.970
A07 Other protozoal intestinal diseases	0.030	0.970
A06 Amoebiasis	0.030	0.970
A05 Other bacterial foodborne intoxications	0.030	0.970
A03 Shigellosis	0.030	0.970
A01 Typhoid and paratyphoid fevers	0.030	0.970
A00 Cholera	0.030	0.970
H54.0 Blindness, both eyes	0.030	0.970
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.030	0.970
H40.1 Primary open-angle glaucoma	0.030	0.970
W06 Fall involving bed	0.030	0.970
M51 Other intervertebral disk disorders	0.030	0.970
S02 Fracture of skull and facial bones	0.030	0.970
H04 Disorders of lachrymal system	0.030	0.970
B25-B34 Other viral diseases	0.030	0.970
G93.3 Postviral fatigue syndrome	0.030	0.970
A48 Other bacterial diseases, not elsewhere classified	0.030	0.970
A44 Bartonellosis	0.030	0.970
A43 Nocardiosis	0.030	0.970
A42 Actinomycosis	0.030	0.970
A40 Streptococcal septicaemia	0.030	0.970
A39 Meningococcal infection	0.030	0.970
A37 Whooping cough	0.030	0.970
A36 Diphtheria	0.030	0.970
A32 Listeriosis	0.030	0.970
A31 Infection due to other mycobacteria	0.030	0.970
A30 Leprosy [Hansen's disease]	0.030	0.970
A46 Erysipelas	0.030	0.970
A38 Scarlet fever	0.030	0.970
A35 Other tetanus	0.030	0.970
A34 Obstetrical tetanus	0.030	0.970
A33 Tetanus neonatorum	0.030	0.970
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.030	0.970
M80 Osteoporosis with pathological fracture	0.030	0.970
H44 Disorders of globe	0.030	0.970
T17 Foreign body in respiratory tract	0.030	0.970
M75 Shoulder lesions	0.030	0.970
N47 Redundant prepuce, phimosis and paraphimosis	0.030	0.970
M54.57 Low back pain (Lumbosacral region)	0.030	0.970
T36.9 Systemic antibiotic, unspecified	0.029	0.970
T36.8 Other systemic antibiotics	0.029	0.970
T36.7 Antifungal antibiotics, systemically used	0.029	0.970
T36.6 Rifamycins	0.029	0.970
T36.5 Aminoglycosides	0.029	0.970
T36.4 Tetracyclines	0.029	0.970
T36.3 Macrolides	0.029	0.970
T36.2 Chloramphenicol group	0.029	0.970
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.029	0.970
T36.0 Penicillins	0.029	0.970
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.029	0.970
T37.8 Other specified systemic anti-infectives and antiparasitics	0.029	0.970
T37.5 Antiviral drugs	0.029	0.970
T37.4 Anthelminthics	0.029	0.970
T37.3 Other antiprotozoal drugs	0.029	0.970
T37.2 Antimalarials and drugs acting on other blood protozoa	0.029	0.970
T37.1 Antimycobacterial drugs	0.029	0.970
T37.0 Sulphonamides	0.029	0.970
T38.9 Other and unspecified hormone antagonists	0.029	0.970
T38.8 Other and unspecified hormones and their synthetic substitutes	0.029	0.970
T38.7 Androgens and anabolic congeners	0.029	0.970
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.029	0.970
T38.5 Other oestrogens and progestogens	0.029	0.970
T38.4 Oral contraceptives	0.029	0.970
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.029	0.970
T38.2 Antithyroid drugs	0.029	0.970
T38.1 Thyroid hormones and substitutes	0.029	0.970
T38.0 Glucocorticoids and synthetic analogues	0.029	0.970
T41.5 Therapeutic gases	0.029	0.970
T41.4 Anaesthetic, unspecified	0.029	0.970
T41.3 Local anaesthetics	0.029	0.970
T41.2 Other and unspecified general anaesthetics	0.029	0.970
T41.1 Intravenous anaesthetics	0.029	0.970
T41.0 Inhaled anaesthetics	0.029	0.970
T45.9 Primarily systemic and haematological agent, unspecified	0.029	0.970
T45.8 Other primarily systemic and haematological agents	0.029	0.970
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.029	0.970
T45.6 Fibrinolysis-affecting drugs	0.029	0.970
T45.5 Anticoagulants	0.029	0.970
T45.4 Iron and its compounds	0.029	0.970
T45.3 Enzymes, not elsewhere classified	0.029	0.970
T45.2 Vitamins, not elsewhere classified	0.029	0.970
T45.1 Antineoplastic and immunosuppressive drugs	0.029	0.970
T45.0 Antiallergic and antiemetic drugs	0.029	0.970
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.029	0.970
T46.8 Antivaricose drugs, including sclerosing agents	0.029	0.970
T46.7 Peripheral vasodilators	0.029	0.970
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.029	0.970
T46.5 Other antihypertensive drugs, not elsewhere classified	0.029	0.970
T46.4 Angiotensin-converting-enzyme inhibitors	0.029	0.970
T46.3 Coronary vasodilators, not elsewhere classified	0.029	0.970
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.029	0.970
T46.1 Calcium-channel blockers	0.029	0.970
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.029	0.970
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.029	0.970
T47.8 Other agents primarily affecting the gastro-intestinal system	0.029	0.970
T47.7 Emetics	0.029	0.970
T47.6 Antidiarrhoeal drugs	0.029	0.970
T47.5 Digestants	0.029	0.970
T47.4 Other laxatives	0.029	0.970
T47.3 Saline and osmotic laxatives	0.029	0.970
T47.2 Stimulant laxatives	0.029	0.970
T47.1 Other antacids and anti-gastric-secretion drugs	0.029	0.970
T47.0 Histamine H(2)-receptor antagonists	0.029	0.970
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.029	0.970
T48.6 Antiasthmatics, not elsewhere classified	0.029	0.970
T48.5 Anti-common-cold drugs	0.029	0.970
T48.4 Expectorants	0.029	0.970
T48.3 Antitussives	0.029	0.970
T48.2 Other and unspecified agents primarily acting on muscles	0.029	0.970
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.029	0.970
T48.0 Oxytocic drugs	0.029	0.970
T49.9 Topical agent, unspecified	0.029	0.970
T49.8 Other topical agents	0.029	0.970
T49.7 Dental drugs, topically applied	0.029	0.970
T49.6 Otorhinolaryngological drugs and preparations	0.029	0.970
T49.5 Ophthalmological drugs and preparations	0.029	0.970
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.029	0.970
T49.3 Emollients, demulcents and protectants	0.029	0.970
T49.2 Local astringents and local detergents	0.029	0.970
T49.1 Antipruritics	0.029	0.970
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.029	0.970
T50.9 Other and unspecified drugs, medicaments and biological substances	0.029	0.970
T50.8 Diagnostic agents	0.029	0.970
T50.7 Analeptics and opioid receptor antagonists	0.029	0.970
T50.6 Antidotes and chelating agents, not elsewhere classified	0.029	0.970
T50.5 Appetite depressants	0.029	0.970
T50.4 Drugs affecting uric acid metabolism	0.029	0.970
T50.3 Electrolytic, caloric and water-balance agents	0.029	0.970
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.029	0.970
T50.1 Loop [high-ceiling] diuretics	0.029	0.970
T50.0 Mineralocorticoids and their antagonists	0.029	0.970
X40-X49 Accidental poisoning by and exposure to noxious substances	0.030	0.970
M54.1 Radiculopathy	0.029	0.970
T19 Foreign body in genito-urinary tract	0.029	0.970
T15 Foreign body on external eye	0.029	0.970
T16 Foreign body in ear	0.029	0.970
M77.0 Medial epicondylitis	0.029	0.970
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.029	0.971
H51 Other disorders of binocular movement	0.029	0.971
H49 Paralytic strabismus	0.029	0.971
W19 Unspecified fall	0.029	0.971
X60-X84 Intentional self-harm	0.029	0.971
M54.8 Other dorsalgia	0.029	0.971
M54.6 Pain in thoracic spine	0.029	0.971
M54.0 Panniculitis affecting regions of neck and back	0.029	0.971
H42 Glaucoma in diseases classified elsewhere	0.029	0.971
B02 Zoster [herpes zoster]	0.029	0.971
M13 Other arthritis	0.029	0.971
N43.3 Hydrocele, unspecified	0.029	0.971
D70-D77 Other diseases of blood and blood-forming organs	0.029	0.971
D50 Iron deficiency anaemia	0.029	0.971
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.029	0.971
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.029	0.971
T39.4 Antirheumatics, not elsewhere classified	0.029	0.971
T39.2 Pyrazolone derivatives	0.029	0.971
H21.8 Other specified disorders of iris and ciliary body	0.029	0.971
H54.4 Blindness, one eye	0.029	0.971
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.029	0.971
A04.8 Other specified bacterial intestinal infections	0.029	0.971
H50.0 Convergent concomitant strabismus	0.029	0.971
T39.0 Salicylates	0.029	0.971
S09.8 Other specified injuries of head	0.029	0.971
S09.7 Multiple injuries of head	0.029	0.971
S09.2 Traumatic rupture of ear drum	0.029	0.971
S09.1 Injury of muscle and tendon of head	0.029	0.971
S09.0 Injury of blood vessels of head, not elsewhere classified	0.029	0.971
S50 Superficial injury of forearm	0.029	0.971
S42 Fracture of shoulder and upper arm	0.029	0.971
H53.6 Night blindness	0.029	0.971
H53.5 Colour vision deficiencies	0.029	0.971
H53.3 Other disorders of binocular vision	0.029	0.971
M54.2 Cervicalgia	0.029	0.971
S19 Other and unspecified injuries of neck	0.028	0.971
S17 Crushing injury of neck	0.028	0.971
S15 Injury of blood vessels at neck level	0.028	0.971
S14 Injury of nerves and spinal cord at neck level	0.028	0.971
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.028	0.971
S12 Fracture of neck	0.028	0.971
S11 Open wound of neck	0.028	0.971
S10 Superficial injury of neck	0.028	0.971
S18 Traumatic amputation at neck level	0.028	0.971
S16 Injury of muscle and tendon at neck level	0.028	0.971
T06 Other injuries involving multiple body regions, not elsewhere classified	0.028	0.971
T05 Traumatic amputations involving multiple body regions	0.028	0.971
T04 Crushing injuries involving multiple body regions	0.028	0.971
T03 Dislocations, sprains and strains involving multiple body regions	0.028	0.971
T02 Fractures involving multiple body regions	0.028	0.971
T01 Open wounds involving multiple body regions	0.028	0.971
T00 Superficial injuries involving multiple body regions	0.028	0.971
T07 Unspecified multiple injuries	0.028	0.971
T25 Burn and corrosion of ankle and foot	0.028	0.971
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.028	0.971
T23 Burn and corrosion of wrist and hand	0.028	0.971
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.028	0.971
T21 Burn and corrosion of trunk	0.028	0.971
T20 Burn and corrosion of head and neck	0.028	0.971
T28 Burn and corrosion of other internal organs	0.028	0.971
T27 Burn and corrosion of respiratory tract	0.028	0.971
T26 Burn and corrosion confined to eye and adnexa	0.028	0.971
T35 Frostbite involving multiple body regions and unspecified frostbite	0.028	0.971
T34 Frostbite with tissue necrosis	0.028	0.971
T33 Superficial frostbite	0.028	0.971
M11 Other crystal arthropathies	0.028	0.971
T75 Effects of other external causes	0.028	0.971
T74 Maltreatment syndromes	0.028	0.971
T73 Effects of other deprivation	0.028	0.971
T70 Effects of air pressure and water pressure	0.028	0.971
T69 Other effects of reduced temperature	0.028	0.971
T67 Effects of heat and light	0.028	0.971
T71 Asphyxiation	0.028	0.971
T68 Hypothermia	0.028	0.971
T66 Unspecified effects of radiation	0.028	0.971
M20-M25 Other joint disorders	0.029	0.971
S99 Other and unspecified injuries of ankle and foot	0.028	0.971
S98 Traumatic amputation of ankle and foot	0.028	0.971
S97 Crushing injury of ankle and foot	0.028	0.971
S96 Injury of muscle and tendon at ankle and foot level	0.028	0.971
S95 Injury of blood vessels at ankle and foot level	0.028	0.971

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations